Real-World Evidence of Eflapegrastim (efla) Usage in Patients with Gastrointestinal (GI) Malignancies

An abstract titled “Real-World evidence of eflapegrastim (efla) usage in patients with gastrointestinal (GI) malignancies” was published by authors Howard Franklin; Jeffrey Crawford; John H. Baird; Kenneth Crist; Vincent Marino; Neil Shah; Lee S. Schwartzberg. The authors are affiliated with Assertio, Duke University Medical Center, City of Hope National Medical Center, Atropos Health and Renown […] The post Real-World Evidence of Eflapegrastim (efla) Usage in Patients with Gastrointestinal (GI) Malignancies appeared first on Atropos Health .